News
Why mRNA Vaccines Are So Revolutionary—And What's at Stake If We Lose Them
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move rooted in a fundamental misunderstanding of vaccinology,” wrote Jake Scott, an infectious diseases specialist and clinical associate professor of medicine at Stanford University, on the social media site Bluesky.
The Trump administration is decreasing funding for the development of mRNA (messenger RNA) vaccines, which were crucial in ...
The company, privately-held Tiba Biotech, received an email minutes after Kennedy’s Tuesday night announcement ordering the ...
Tiba Biotech, another research company that saw its HHS contracts terminated Tuesday, is investigating using mRNA to combat ...
RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...
Secretary Robert F. Kennedy Jr. said his department would slash funding for mRNA vaccine research and shift its focus to ...
Barchart on MSN16h
Moderna Stock: Is Wall Street Bullish or Bearish?With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...
Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...
All living organisms' genetic information is stored in DNA, which is transcribed into RNA, which is translated into proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback